The stock ended flat at Rs 1,140. The counter witnessed trades of 66,152 shares as compared to the two-week daily average traded volumes of 48,654 shares.
______________________________________________________
(Updated at 1001hrs)
Pharma major, Lupin has gained in early trades on acquiring cholestrol drugs for $39 million.
The stock opened at Rs 1,150 and touched a low of Rs 1,140. It surged to a high of Rs 1,185 - up 4.5% from the previous close. The stock is now up 2.8% at Rs 1,167. The stock has added 9% in the past week. Around 1,823 shares have been traded on the BSE so far.
The company has acquired the US rights for Oscient Pharma's cholestrol lowering drug, Antara. Bankrupt company, Oscient Pharma has been paid Rs 188 crore for the acquisition. The drug has had sales of Rs 337.5 crore in the US market last year.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app